article thumbnail

Immunovant data show potential for autoimmune disease drug

Bio Pharma Dive

Much anticipated clinical trial data for Immunovant’s experimental FcRn inhibitor could catalyze business development decisions for its parent, Roivant Sciences.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Gareth Powell is a business development officer for the NIHR Clinical Research Network (CRN).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Russia: Pfizer stops clinical trials, Bayer halts investment projects

BioPharma Reporter

Pfizer Inc says it will maintain its supply of medicines to Russia but it will not initiate new clinical trials in the country, while Bayer is suspending investment projects and new-business development in that market.

article thumbnail

Ride4DEI Promotes Stronger Clinical Trial Industry

Velocity Clinical Research

in an effort to raise money and awareness promoting diversity on all levels in clinical trials. But obstacles loom for the plucky bikers, says Sergio Armani, ACRP Ride4DEI Creator, and EVP, Business Development, Helios Clinical Research. Learn more about Velocity's involvement with the ACRP Ride4DEI →.

article thumbnail

The evolution of clinical trials: the pharmaphorum podcast

pharmaphorum

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo executive vice president and general manager of Worldwide Clinical Trials Early Phase Services, Keith Fern. Keith Fern joins Elligo with a decade of proven leadership in the CRO industry.

article thumbnail

Innovative Program Expands Clinical Trial Workforce, Patient Outreach in Hispanic Communities

ACRP blog

Just ask Michaele Linden-Johnson, FACHE, MBA, LCSW, director of clinical trials and business development at the Medical Center of the Americas (MCA) Foundation Cardwell Collaborative in El Paso, Texas. We’re all about developing a workforce designed to reflect our patient population,” Linden-Johnson says.

article thumbnail

How a new investment is powering a revolution in clinical trial operations

pharmaphorum

Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. While many pieces of the drug development process have digitised to keep pace with the speed of technological advancements, clinical trials continue to lag amidst pharma’s digital transformation.